Skip to main content

Home/ Healthcare 2.0/ Group items tagged Inhibitors

Rss Feed Group items tagged

sanyukta_k

Immune Checkpoint Inhibitors Market by Type (PD-1 Inhibitors, PD-L1 Inhibitor... - 0 views

  •  
    The immune checkpoint inhibitors market was negatively impacted by the COVID-19 pandemic. Owing to decline in number of cancer patient visits in hospitals and clinics for immune checkpoint inhibitors therapies which lead to decline in the demand of immune checkpoint inhibitors products. For instance, according to AstraZenca PLC, Opidivo (immune checkpoint inhibitor) registered a 5.6 % decline in
sanyukta_k

Interleukin Inhibitors Market Overview and Industry Forecast, 2026 - A Market Place Res... - 0 views

  •  
    The interleukin inhibitor market is segmented on the basis of application, type, distribution channel and region. The applications covered in the study include psoriasis, psoriatic arthritis, rheumatoid arthritis, asthma, inflammatory bowel disease, transplant rejection and others.
sachin_cmi

What are the various Gastroesophageal Reflux Disease (GERD) Treatment Devices available... - 0 views

  •  
    Gastroesophageal Reflux Disease (GERD) is a chronic condition that is characterized by the regurgitation of stomach contents into the throat. GERD is also known as acid reflux disease and it occurs in people of all ages. In milder cases, GERD can be effectively treated with simple pharmacological therapies or by altering a patient's diet. In more severe cases, esophageal surgery might be necessary to remove the troublesome esophageal sphincter and/or improve a patient's general physical condition. GERD can develop when the lower esophageal valve relaxes or becomes weakened. The diagnosis of GERD and gastroesophageal reflux disease can be done by examining the medical history and symptoms. Although acid-reflux disease typically affects the upper body, some of its symptoms can extend down the esophageal tract, making GERD particularly troubling for people who sit or stand for long periods of time. This problem has given rise to a variety of different approaches to treatment, including invasive, surgical treatments, non-surgical treatments and more novel, non-invasive therapeutic approaches. The latest treatment option on the table involves using pharmaceuticals, such as selective serotonin reuptake inhibitors (SSRIs), to help reduce the effects of GERD. There are a number of advantages to this strategy. For starters, SSRIs are believed to have numerous side effects that tend to make them less attractive to certain groups of patients. Electrical stimulation (ESD) is another common form Gastroesophageal Reflux Disease (GERD) Treatment Devices. This technique involves the use of electrodes attached to the esophageal wall to generate a varying amount of electrical current. Antirheumatic drugs, which often cause symptoms similar to those of severe heart disease, are sometimes added to the mixture. A major disadvantage of using plicator devices with ESD is that the procedure can only be performed on an outpatient basis, requiring a patient to remain in the hospital for a fe
sachin_cmi

Multiple Myeloma Drugs are Getting Better with Major Pharmaceutical Companies Laying Em... - 0 views

  •  
    Multiple myeloma is a type of cancer that forms a type of white blood cell called a plasma cell. In multiple myeloma, cancerous plasma cells gather around the bone marrow and crowd out healthy cells. Some of the most common symptoms of multiple myeloma are pain in the back or bones, anemia, fatigue, and kidney damage. Multiple myelomas can be identified by a biopsy, which is conducted when tissue samples from the affected area are taken and examined under a microscope. When multiple myelomas are detected on an examination, it is typically very easy to remove them with a scalpel, and in many cases, surgeons will opt to remove only one lobe of tissue at a time. There has the development of various multiple myeloma drugs over the years with key industry players being involved in continuous research and development activities. Selinexor is one of the latest U.S. FDA-approved drug for multiple myeloma and is used to treat people suffering from relapsed or refractory disease. Furthermore, Ixazomib is the first and only oral proteasome inhibitor, indicated for multiple myeloma treatment. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2020/12/multiple-myeloma-drugs-are-getting.html
1 - 10 of 10
Showing 20 items per page